Gregory Critchfield

Epic Sciences has appointed Sera Prognostics President and CEO Gregory Critchfield to its board. He has more than 30 years of experience in the clinical pathology and diagnostics space and was the former president of Myriad Genetics. Prior to that, Critchfield was chief medical and science officer for Quest Diagnostics. He currently is also on the boards of Integrated Diagnostics, Nodality, and Metamark Genetics.